pre-update Archives

Blog

罕见病药物开发模型的实用性

Model-informed drug development (MIDD) is a network of closely integrated ecosystems that can seamlessly position…

Certara2022 年 5 月 20 日

Announcement

Certara Earns 2022 Great Place to Work Certification™

Princeton, NJ, 2022 年 5 月 17 日. Certara, Inc., a global leader in biosimulation, today announced that…

Certara2022 年 5 月 17 日

Fact Sheet

CoAuthor™ 概况介绍

在本事实资料表中了解 CoAuthor™ 的主要特性与优势

Jim Gallagher2022 年 5 月 16 日

On-Demand Webinar

有问必答：法规与医学撰写领域的职业机会

Have you ever wondered what it would be like to be a Regulatory or Medical…

Jim Gallagher2022 年 5 月 12 日

On-Demand Webinar

Approaches to Address the Regulatory Requirements for System Qualification of the Simcyp Simulator

Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary clinical…

Jim Gallagher2022 年 5 月 9 日

Poster

Prediction of drug-drug interactions with oxycodone and pupil constriction using a physiologically based pharmacokinetic-pharmacodynamic model

海报

vicky2022 年 4 月 29 日

Announcement

P21 Adds Support for CDISC Open Rules Engine (CORE)

P21 is proud to announce that support for CDISC Open Rules Engine (CORE) is now available…

Certara2022 年 4 月 25 日

Announcement

Pinnacle 21 Releases P21 Community 4.0

As of 2022 年 4 月 25 日, we have released P21 Community 4.0 to general availability! Install…

Certara2022 年 4 月 25 日

On-Demand Webinar

更智能的临床文件自动化，满足透明度和信息披露要求

Transparency and disclosure efforts are an integral part of medical writing for submissions. Sponsors receive…

Jim Gallagher2022 年 4 月 14 日

Blog

Phoenix WinNonlin 助力 PK/PD 分析的 5 大核心优势

Pharmaceutical companies around the globe face the challenge of increasingly longer drug development cycles and…

Certara2022 年 3 月 25 日

pre-update

罕见病药物开发模型的实用性

Certara Earns 2022 Great Place to Work Certification™

CoAuthor™ 概况介绍

有问必答：法规与医学撰写领域的职业机会

Approaches to Address the Regulatory Requirements for System Qualification of the Simcyp Simulator

Prediction of drug-drug interactions with oxycodone and pupil constriction using a physiologically based pharmacokinetic-pharmacodynamic model

P21 Adds Support for CDISC Open Rules Engine (CORE)

Pinnacle 21 Releases P21 Community 4.0

更智能的临床文件自动化，满足透明度和信息披露要求

Phoenix WinNonlin 助力 PK/PD 分析的 5 大核心优势

订阅时事通讯

快捷链接

解决方案

联系我们